12:00 AM
Jul 20, 2009
 |  BC Week In Review  |  Company News  |  Other News

Alnylam chemistry news

The European Patent Office upheld Alnylam's European Patent No. EP 1352061 which is part of the Kreutzer-Limmer II patent family. The patent covers the inhibition of about 130 disease targets using double-stranded RNAs...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >